JACOB A BISHOP

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry LEXINGTON, KY NPI 1013324136

General Payments — all program years on this page

$1,710.06

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 94
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $354.71 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $354.7120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $157.154
2020 $70.374
2021 $128.277
2022 $444.0328
2023 $555.5331
2024 $354.7120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078026568 Janssen Pharmaceuticals, Inc $14.87 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118863159 Otsuka America Pharmaceutical, Inc. $17.86 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467636 Alkermes, Inc. $25.84 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467638 Alkermes, Inc. $17.38 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467640 Alkermes, Inc. $16.14 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467642 Alkermes, Inc. $18.79 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467644 Alkermes, Inc. $14.15 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467646 Alkermes, Inc. $22.35 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467648 Alkermes, Inc. $25.69 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467650 Alkermes, Inc. $19.17 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467652 Alkermes, Inc. $16.14 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467654 Alkermes, Inc. $17.88 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120467656 Alkermes, Inc. $12.77 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133897085 Vanda Pharmaceuticals Inc. $15.29 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145897978 Lundbeck LLC $21.29 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145897980 Lundbeck LLC $17.67 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146282858 IRONSHORE PHARMACEUTICALS INC. $13.33 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146282870 IRONSHORE PHARMACEUTICALS INC. $15.21 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146283058 IRONSHORE PHARMACEUTICALS INC. $17.61 04/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148286335 Axsome Therapeutics, Inc. $15.28 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.